Antibodies that specifically bind to the EphA2 receptor

Details for Australian Patent Application No. 2010302250 (hide)

Owner Sanofi

Inventors Bouchard, Herve; Commercon, Alain; Fromond, Claudia; Mikol, Vincent; Parker, Fabienne; Sassoon, Ingrid; Tavares, Daniel

Agent A J Park

Pub. Number AU-A-2010302250

PCT Pub. Number WO2011/039724

Priority 09305938.4 02.10.09 EP

Filing date 30 September 2010

Wipo publication date 7 April 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/039724 Priority application(s): WO2011/039724

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010302255-Use of siRNA targetting Sipa1l1 for the reduction of adipogenesis

2010302247-New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody